top of page

Databases & Sample Sharing

Biobank and Sample Sharing

As part of the Networking Activities of the TRANSVAC2 project, a database of the types of sample collections available at partner institutes has been established. These collections include different animal study derived products (sera, tissues etc.), mainly involving a biohazard level 3 or 4 for mice, NHP and non-rodent animals. These collections will continue to be developed during the project lifetime. Interested applicants are encouraged to contact directly TRANSVAC partner or transvacinvo@euvaccine.eu.

Overview of materials available through TRANSVAC2 The list is not exhaustive and its purpose is to initiate an individual discussion between a potential user and TRANSVAC partner (sample type, IP issues should be arranged case by case basis).

Sample Sharing - Overview.png

TRANSVAC2 and other biobank projects

There are several other biobank networks/projects – funded by the EU or other bodies – which TRANSVAC2 is aware of and will be listed in this section. TRANSVAC2 and its partners support these networks/projects, encourage researchers to use them and do not intend to offer materials which are already available through existing biobanks:

 

Regulatory Databases

Regulatory Support Databases

TRANSVAC2 Partner, ECRIN (European Clinical Trial Research Infrastructure Network) makes available a resource for information about clinical trial regulatory and ethical requirements covering 22 European countries and multiple study types such as clinical drug trials, clinical investigations of medical devices, combination drug-device studies and nutritional studies.

 

TRANSVAC2 Partner, EATRIS (European infrastructure for translational medicine) makes available a Regulatory Information system database. Potential users of the database shall contact EATRIS via link bellow.

Alternative Methods to Animal Models

TRANSVAC seeks to contribute to the 3Rs (Replacement, Reduction and Refinement) principle by providing the scientific community with Open Science tools and information to identify, develop and use 3R-based technologies to validate human and veterinary vaccines. Descriptions and information on non-animal methods are collected below.

 

 
 
bottom of page